X4 Pharmaceuticals, Inc.
(NASDAQ : XFOR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.14%46.498.1%$739.63m
AMGNAmgen Inc.
0.35%176.731.3%$505.34m
CELGCelgene Corporation
0.07%91.821.3%$444.49m
GILDGilead Sciences, Inc.
-1.53%67.030.9%$405.18m
BIIBBiogen Inc.
-0.26%233.011.3%$386.66m
ILMNIllumina, Inc.
0.09%302.553.5%$336.07m
REGNRegeneron Pharmaceuticals, Inc.
-0.06%298.022.6%$277.99m
SRPTSarepta Therapeutics, Inc.
-2.58%152.8714.7%$203.49m
ALXNAlexion Pharmaceuticals, Inc.
0.70%123.902.0%$199.53m
VRTXVertex Pharmaceuticals Incorporated
0.30%176.891.9%$188.04m
EXASExact Sciences Corporation
-0.29%115.8524.1%$140.08m
AAgilent Technologies, Inc.
-0.91%69.911.6%$134.04m
INCYIncyte Corporation
-1.36%80.282.5%$114.51m
BLUEBluebird Bio, Inc.
-1.38%133.8814.3%$97.84m
BMRNBioMarin Pharmaceutical Inc.
-1.73%82.544.3%$87.82m

Company Profile

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.